Holen Sie sich die Stockscreener-App
1.94
3.74%
0.07
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.88%
1.8854
|
1.7641 | - | 2.2673 | 1.9407 |
| Operating Income/Loss |
6.88%
-1.8854
|
-1.7641 | - | -2.2673 | -1.9407 |
| Nonoperating Income/Loss |
274.61%
-0.1108
|
-0.0296 | - | 0.0385 | -0.1301 |
| Income/Loss Before Equity Method Investments |
7.34%
-1.8428
|
-1.7167 | - | -2.0657 | -1.962 |
| Income/Loss From Equity Method Investments |
99.41%
-0.1534
|
-0.0769 | - | -0.1631 | -0.1088 |
| Income/Loss From Continuing Operations Before Tax |
11.29%
-1.9962
|
-1.7937 | -1.9586 | -2.2288 | -2.0708 |
| Income/Loss From Continuing Operations After Tax |
11.29%
-1.9962
|
-1.7937 | -1.9586 | -2.2288 | -2.0708 |
|
Net Income/Loss
|
11.29%
-1.9962
|
-1.7937 | -1.9586 | -2.2288 | -2.0708 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
156.39%
-12.50
|
22.17 | - | - | - |
| Diluted Average Shares |
156.39%
-12.50
|
22.17 | - | 6.5398 | 0.5213 |
| Basic Earnings Per Share |
14,250%
-11.48
|
-0.08 | - | -0.34 | -0.15 |
| Diluted Earnings Per Share |
14,250%
-11.48
|
-0.08 | - | -0.34 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):